Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00374764|
Recruitment Status : Completed
First Posted : September 11, 2006
Last Update Posted : February 16, 2007
- Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment.
- Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone.
- Young age, cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment.
- At baseline, children with ASDs will show significantly lower performances on measures of cognitive, neuropsychological, and socio-emotional functioning than age-matched typically developing controls.
|Condition or disease||Intervention/treatment|
|Autistic Disorder||Drug: Risperidone Behavioral: ABA|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone|
|Study Start Date :||July 2000|
|Estimated Study Completion Date :||June 2002|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00374764
|United States, Missouri|
|Early Emotional Development Program|
|St. Louis, Missouri, United States, 63108|
|Principal Investigator:||Joan Luby, MD||Washington University Medical School|